WuXi PharmaTech signs new collaboration agreement with Pfizer
WuXi PharmaTech a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced revently that it has signed a new three-year, in vitro ADME collaboration agreement with Pfizer.
Pfizer, the US pharmaceuticals group, is in talks to acquire rival Wyeth, a deal that would create new drugs giant with a market value of around $60bn.